fda takes tirzepatide off shortage list Minus one of its GLP-1 cash cows, compounding group sues FDA Allows Compounded Tirzepatide During

Do not discontinue or skip Mounjaro doses without medical advice, as this may affect glycaemic control in patients with diabetes

Make sure there are no cracks in the casing

Furthermore, as outlined previously IGF signalling is integrated with nutritional status and metabolism and now more than ever a focus on lifestyle interventions such as diet and exercise is necessary

As of 2025, retatrutide has not received a UK marketing authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA), which is the licensing authority for Great Britain

NICE guidance specifies continuation criteria and typically limits tirzepatide treatment duration to up to two years within specialist weight management services

For more trusted health insights, visit Doctronic